Pure Global

HCV Rapid - India CDSCO Medical Device Registration

HCV Rapid is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000045_566169e677bc6726f42837c7514700e9_b493c55b24d587b8566c1981cbcca6be. The license holder is Promea Therapeutics Private Limited, and it is classified as Device Class Class D. The approving authority is CDSCO, Zonal office, Hyderabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
HCV Rapid
UID: MFG/IVD/2022/000045_566169e677bc6726f42837c7514700e9_b493c55b24d587b8566c1981cbcca6be

Device Class

Class D

Approving Authority

CDSCO, Zonal office, Hyderabad

Product Information

The HCV Rapid Test is a double antigen lateral flow chromatographic immunoassay for the qualitative detection of antihepatitis C virus antibodies ##PLACEHOLDER_0## in human serum/plasma. It is intended to be used as a screening test and as an aid in the diagnosis of infection with HCV.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing